December 3, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

Registration Now Open! NRG Oncology Semiannual Meeting in Phoenix.
Read more

The NCI CIRB has issued a guidance document for NCI informed consent template language to ensure compliance. The document can be found on the  CIRB website.
 

Help Celebrate Our Birthday at the NRG Oncology Semiannual Meeting in Phoenix
We hope you can join us for the NRG Oncology Semiannual Meeting and Birthday Celebration, February 7-9, 2019 at the Phoenix Convention Center in Phoenix, AZ.
Registration deadline is January 14, 2019!

 
Our Gift to You

It’s our birthday, and we are celebrating the reason for our success – our members! We are extending our birthday gift to you. In honor of our 5th birthday, NRG Oncology is waiving the registration fee for all NRG Oncology members. Please be sure to  Click here to register Today!


AMENDMENTS
BRAIN

RTOG 1122: Received Health Canada approval for Amendment 12. Sites in Canada may access the NOL and Health Canada forms on the NRG website.


OTHER PROTOCOL NOTICES
1. BRAIN

NRG-BN005: Newsletter available on CTSU


2. BREAST

NRG-BR005: E-mail Blast (posted on CTSU)


3. GYNECOLOGIC
Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus
Please note that the NRG Patient ID (e.g., AB###-GY###-#####) must be included on any copies of Form TR shipped to the NRG Biospecimen Bank-Columbus.

If the NRG Patient ID does not appear on the top, left of Form TR, please hand-complete the NRG Patient ID before sending the form to the NRG Biospecimen Bank-Columbus. Do not complete the NRG Patient ID for forms accompanying biospecimens shipped to laboratories other than the NRG Biospecimen Bank-Columbus.Please contact the NRG Biospecimen Bank-Columbus at bpcbank@nationwidechildrens.org if you need assistance or if you have additional questions.

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment
Please be advised that the data exchange between the Biospecimen Bank-Columbus and SDMC is undergoing refurbishment. During this time, biospecimen receipt information will not appear in Rave or SEDES. Biospecimen transmittal forms (i.e., Form SP and Form TR) will ultimately not appear as overdue during this time; however, there may be a brief period over the next several weeks during which forms may temporarily appear as overdue. If this should occur or if you experience any other issues, please notify Support at support@nrgoncology.org. Sites should continue to return inquiries from Biospecimen Bank-Columbus staff regarding biospecimen receipt during this time.

4. LUNG

NRG-LU002: The webinar for NRG-LU002 is now available on the NRG Oncology website. We will be hosting a follow up “Ask the PI” session for NRG-LU002.  Read more here

NRG-LU005: Save the date for the LU005 Information Session.  Read more here

5. HEAD and NECK

NRG-HN004: Save the date for the Protocol Update and Training Session for NRG-HN004.  Read more here

6. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for December 5, 2018.

 


DRUG SAFETY UPDATES
Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Atezolimumab

NRG-GY009

NRG-GY017

CTSU

NRG

Cabozantinib

NRG-GY001

CTSU

Entinostat

NRG-GY011

CTSU

Ipilimumab

NRG-BN002

NRG-GY003

NRG

NRG

Nivolumab

NRG-BN002

NRG-GY003

NRG

NRG

Olaparib

NSABP B-55

CTSU

Pembrolizumab

NRG-GY016

NRG-HN003

CTSU

NRG

 

New deadline for posting national coverage analyses (NCAs) on the CTSU website at trial activation for all new NCTN protocols starting January 2, 2019. Read letter here

The NCI CIRB has issued a guidance document for NCI informed consent template language to ensure compliance. The document can be found on the CIRB website.

 

REGISTER TODAY FOR THE NRG-LU002 “ASK THE PI” WEBINAR SESSION

NRG Oncology will be hosting an “Ask the PI” question and answer format webinar session for NRG-LU002: Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial. Attendees will be in listen-only mode, but we asked that all attendees submit questions via the “Questions” section of the GoToWebinar application. The study Principal Investigator, Dr. Puneeth Iyengar, will be answering the questions as they appear. Register here today: https://attendee.gotowebinar.com/register/4988138304214505729


NRG ONCOLOGY AND TOCAGEN TO COLLABORATE ON A PHASE II/III Trial of TOCA 511 & TOCA FC IN NEWLY DIAGNOSED GLIOBLASTOMA
NRG Oncology and Tocagen Inc., a late clinical-stage, cancer-selective gene therapy company, announced that the NCI Cancer Therapy and Evaluation Program (CTEP) Brain Malignancies Steering Committee has approved a concept to develop a clinical trial utilizing the investigational therapeutic regimen Toca 511 (vocimagene amiretrorepvec) & Toca FC (flucytosine, extended-release) for the treatment of patients with newly diagnosed glioblastoma (GBM). Read the press release here.

 

SAVE THE DATE: PROTOCOL UPDATE AND TRAINING SESSION FOR NRG-HN004

NRG Oncology will be holding a protocol update/training session for NRG-HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin on Friday, February 8, 2019 from 11:00AM-12:00PM MST at the NRG Oncology Semiannual Meeting. The session is open to all attendees. More information on the training session, agenda, and room location will be released soon. Please contact Erin Moye at moyee@nrgoncology.org for any questions at this time.


SAVE THE DATE: INFORMATION SESSION FOR NRG-LU005

NRG Oncology will be holding an information session for NRG-LU005: Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab on Saturday, February 9, 2019 from 10:00 – 10:30 AM MST at the NRG Semiannual Meeting. This session is open to all attendees.

More information on the session, agenda, and room location will be released soon.

Please contact Erin Moye at moyee@nrgoncology.org for any questions at this time.

 

NRG Oncology 2018 SABCS Annual Meeting Presentation Schedule

The SABCS Annual Meeting is being held December 4-8, 2018 in San Antonio, TX. Presentations by NRG Oncology researchers are posted on the NRG Oncology website.


NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Lieberman FS, Wang M, Tsien CI, Robins HI, Curran WJ Jr., Werner-Wasik M, Smith RP, Schultz CJ, Hartford AC, Zhang P, Mehta MP. Phase II study of radiation therapy plus low dose Temozolomide followed by Temozolomide and Irinotecan for glioblastoma multiforme: NRG Oncology/RTOG 0420. Int J Radiat Oncol Biol Phys. 2018 Nov 27. pii: S0360-3016(18)33955-5.  Read more

 

 

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
American Society of Clinical Oncology (ASCO) GI; Jan 17-19, 2019; San Francisco, CA

San Antonio Breast Cancer Symposium (SABCS); Dec 4-8, 2018; San Antonio, TX

Upcoming Abstract Submission Deadlines

American Association for Cancer Research (AACR); Mar 29 - Apr 3, 2019; Atlanta, GA; LBA submission due Jan 10, 2019

American Brachytherapy Society (ABS); Jun 13-15, 2019; Miami, FL; due to publications committee Dec 28, 2018; meeting submission deadline Jan 11, 2019 4pm CT

American College of Radiology (ACR); May 18-22, 2019 ; Washington DC; meeting submission deadline Dec 14, 2018 5 pm

American Society of Clinical Oncology (ASCO); May 31-Jun 4, 2019; Chicago, IL; due to publications committee Jan 29, 2019; meeting submission deadline Feb 12, 2019; LBA 3-14-19 noon

American Society for Radiation Oncology (ASTRO); Sep 15-18, 201 9;Chicago, IL; due to publications committee Jan 30, 2019; meeting submission deadline Feb 13, 2019

ESMO Breast Cancer Annual Congress; May 2-4, 2019; Berlin, Germany; due to publications committee Jan 16, 2019; meeting submission deadline Jan 30, 2019 TIP, LBA placeholder-Noon CntEuropeTime; LBA deadline Apr 19, 2019

Society of Gynecologic Oncology (SGO); Mar 16-19, 2019; Honolulu, HI; deadline for LBA Dec 5, 2018 to Jan 7, 2019

St. Gallen Breast Cancer Conference (SG-BCC); Mar 20-23, 2019; Vienna, Austria; meeting submission deadline Dec 15, 2018

 

 

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse